Dr. Mark Legaz received a Ph.D. in biochemistry from the University of Washington in Seattle, and did his post doctoral research in clinical chemistry at the University of Washington. He is the President and CEO of Intersect Systems, Inc., a medical diagnostic products company. Mark also founded and is a consultant to Catch, Inc, of Seattle, Washington, whose diagnostic technologies were acquired by Axis-Shield of Scotland.
Mark Legaz, PH.D.
Scientific Advisor, Investor